Jin Su

Title: Jin Su - Innovator in Immunogenic Compositions

Introduction

Jin Su is a notable inventor based in Markham, Canada. He has made significant contributions to the field of immunology, particularly through his innovative patent related to immunogenic compositions.

Latest Patents

Jin Su holds a patent for immunogenic compositions that provide compositions comprising a Chlamydial major outer membrane protein, referred to as 'MOMP', from at least one Chlamydial serovar and an adjuvant. The adjuvant in his invention comprises the product E6020, which has the CAS Number 287180-63-6. The composition may also include at least one carrier system, such as an emulsion or mineral particle. The MOMP protein can be derived from various species, and the invention outlines methods for inducing an immune response in a subject by administering the composition.

Career Highlights

Throughout his career, Jin Su has worked with prominent companies in the pharmaceutical industry, including Sanofi Pasteur Inc. and Sanofi Pasteur S.A. His work has focused on developing innovative solutions to enhance immune responses, showcasing his expertise in the field.

Collaborations

Jin Su has collaborated with notable professionals in his field, including Scott Gallichan and Ausra Mancevski. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Jin Su is a distinguished inventor whose work in immunogenic compositions has the potential to impact the field of immunology significantly. His innovative approach and collaborations highlight his commitment to advancing medical science.